Allenex AB: Tulane Starts a Prospective Trial of XM-ONEĀ® in Kidney Transplantation  
5/29/2012 11:23:48 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): Tulane University Hospital, New Orleans, LA, USA will in May start a prospective trial in Kidney Transplantation investigating the potential of cross match XM-ONEĀ® as part of the risk assessment of their patients.